SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Veröffentlichungen 2004

 

Attaran M, Schneider A, Grote C, Zwiens C, Flemming P, Gratz KF, Jochheim A, Bahr MJ, Manns MP, Ott M:
Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal
hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits.
J Hepatol 2004; 41(5): 837-44

 

Bading S, Mossinger E, Rosenthal H, Länger F, Bastian L:
[Osteosarcoma of the pelvis: Two case reports and review of the literature].
Unfallchirurg 2004; 107(7): 625-32

 

Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K,
Laudeley R, Niemczyk E, Guler F, Menne J, Haller H, Fliser D:
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial
Akt and attenuates progressive organ failure.
Circulation 2004; 110(8): 1006-12

 

Bock O, Neusch M, Büsche G, Mengel M, Kreipe H:
Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes
derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis.
Eur J Haematol 2004; 72: 239-44

 

Bock O, Tessema M, Serinsöz E, von Wasielewski R, Büsche G, Kreipe H:
Aberrant expression of Insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic
myeloproliferative disorders.
Leuk Res 2004; 28(11): 1147-53

 

Bock O, Schlué J, Mengel M, Büsche G, Serinsöz E, Kreipe H:
Thrombopoietin receptor (Mpl) gene expression by megakaryocytes in myeloproliferative disorders.
J Pathol 2004; 203(1): 609-15

 

Bock O, Serinsöz E, Schlué J, Kreipe H:
Different expression levels of the telomerase catalytic subunit hTERT in myeloproliferative and myelodysplastic diseases.
Leuk Res 2004; 28(5): 455-458

 

Brakensiek K, Länger F, Kreipe H, Lehmann U:
Low level of DAP kinase methylation in myelodysplastic syndrome.
Blood 2004; 104(5): 1586-8 [letter]

 

Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB,
Schirmacher P:
Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like
growth factor II overexpression.
Cancer Res 2004; 64(17): 6058-64

 

Buesche G, Freund M, Hehlmann R, Georgii A, Ganser A, Hecker H, Heimpel H, Fonatsch C, Heinze B, Pfirrmann M,
Holgado S, Schmeil A, Tobler A, Hasford J, Buhr T, Kreipe HH:
German CML Study Group
Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response:
meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.
Leukemia 2004;18(9): 1460-7

 

Caselitz M, Masche N, Flemming P, Stern C, Manns MP, Wagner S, Kubicka S:
Prognosis of hepatocellular carcinoma according to new staging classifications.
Dtsch Med Wochenschr 2004; 129(33): 1725-30

 

Dahlke MH, Aselmann H, Ceylan D, Bellin T, Flemming P, Meier PN, Oldhafer K, Klempnauer J, Schlitt HJ, Piso P:
Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis:
results of an experimental model.
Surg Today 2004; 34(4): 349-53

 

Fiebeler A, Park JK, Muller DN, Lindschau C, Mengel M, Merkel S, Banas B, Luft FC, Haller H:
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
Am J Kidney Dis 2004; 43(2):

 

Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, Wilkens L, Heinsch M, Willems H,
Aivado M, Aul C:
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q)
including band q31.
Leukemia 2004; 18(1): 113-9

 

Kreft A, Wiese B, Weiss M, Choritz H, Buhr T, Büsche G, Georgii A:
Analysis of Risk Factors of the Evolution of Myelofibrosis in Pre-Fibrotic Chronic Idiopathic Myelofibrosis:
A retrospective study based on follow up biopsies of 70 patients by using the RECPAM method.
Leukemia Lymphoma 2004; 45(3): 553-9

 

Kruger M, Behrens J, Länger F, Manns MP, Meier PN:
Intramucosal adenocarcinoma of the appendix.
Endoscopy 2004; 36(6): 565; author reply 566.

 

Länger F, Luck HJ, Kreipe HH:
[Morphological response to therapy of breast carcinoma].
Pathologe 2004; 25(6): 455-60

 

Länger F, Stickel J, Tessema M, Kreipe H, Lehmann U:
Overexpression of delta-like kinase (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.
Leuk Res 2004; 28: 1081-3

 

Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R:
Expression of p27 and its ubiquitin ligase subunit SKP2 in upper urinary tract transitional cell carcinoma.
Urology 2004; (im Druck)

 

Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R:
Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary
and metastatic tumour tissues using a tissue microarray technique.
Virchows Arch. 2004; 445(6): 631-6

 

Lehmann U, Brakensiek K, Kreipe H:
Role of epigenetic changes in hematological malignancies.
Ann Hematol. 2004; 83(3): 137-52

 

Lehmann U, Länger F, Celikkaya G, Lück H J,Kreipe H:
Epigenetische Alterationen im Mammakarzinom durch aberrante Promotormethylierung.
Zentralbl Gynäkol 2004; 126: 272-4

 

Lucke T, Marwedel KM, Kanzelmeyer NK, Hori A, Offner G, Kreipe HH, Ehrich JH, Das AM:
Generalized atherosclerosis sparing the transplanted kidney in Schimke disease.
Pediatr Nephrol 2004; 19(6): 672-5

 

Luedde T, Tacke F, Chavan A, Länger F, Klempnauer J, Manns MP:
Yersinia infection mimicking recurrence of gastrointestinal stromal tumor.
Scand J Gastroenterol 2004; 39(6): 609-12

 

Martin JH, Potthoff A, Ledig S, Cornberg M, Jandl O, Manns MP, Kubicka S, Flemming P, Athmann C, Beil W,
Wagner S:
Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells
and their role in apoptosis.
Helicobacter 2004; 9(5): 371-86

 

Mengel M, Jonigk D, Marwedel M, Kleeberger W, Bredt M, Bock O, Lehmann U, Gwinner W, Haller H, Kreipe H:
Tubular Chimaerism occurs regularly in Renal Allografts and is not correlated to the outcome.
J Am Soc Nephrol 2004; 15: 978-86

 

Mengel M, Jonigk D, Wilkens L, Radermacher J, von Wasielewski R, Lehmann U, Haller H, Kreipe H:
Chimerism of Metanephric Adenoma but not of Carcinoma in Kidney Transplants.
Am J Pathol 2004; 165: 2079-85

 

Mengel M, Lehmann U, Jonigk D, Kleeberger J, Kreipe H:
Role of stem cell trafficking and donor-recipient cellular chimerism in lung transplantation.
Curr Opin Organ Transpl 2004; 9: 332-6

 

Mengel M, Kreipe H, Radermacher J:
Pathologie von Virusinfektionen nach Nierentransplantation (Übersichtsarbeit)
Nieren Hochdruck 2004; 33(7): 365-375

 

Mengel M, Müller I, Behrend M, von Wasielewski R, Radermacher J, Schwarz A, Haller H, Kreipe H:
Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
Transplant Int 2004; 17: 293-300

 

Pape L, Mengel M, Offner G, Ehrich JH:
Cyclosporin A-induced remission of primary membranous glomerolunephritis in a child.
Nephrol Dial Transplant 2004; 19(12): 3207

 

Pape L, Mengel M, Offner G, Melter M, Ehrich JH, Strehlau J:
Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool
in chronic allograft nephropathy.
Pediatr Transplant Dec 2004; 8(6): 565-70

 

Pethig K, Genschel J, Peters T, Wilhelmi M, Flemming P, Lochs H, Haverich A, Schmidt HH:
LMNA Mutations in Cardiac Transplant Recipients.
Cardiology 2004; 103(2): 57-62; [Epub ahead of print]

 

Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP,Rudolph KL:
Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
Hepatology 2004;40(1) :80-6

 

Plentz RR, Muller CC, Laenger F, Manns MP, Meier PN:
Lichen planus esophagitis without skin, genital or oral mucosa involvement.
Z Gastroenterol 2004; 42(5): 379-82

 

Rauh D, Graentzdoerffer A, Granderath K, Andreesen JR, Pich A:
Tungsten-containing aldehyde oxidoreductase of Eubacterium acidaminophilum.
Eur J Biochem 2004; 271(1): 212-9

 

Serinsöz E, Neusch M, Büsche G, von Wasielewski R, Kreipe H, Bock O:
Aberrant expression of ß-Catenin discriminates Acute myeloid leukemia (AML) from Acute lymphoblastic leukemia (ALL).
Brit J Haematol 2004; 126(3): 313-9

 

Stadler M, Germing U, Kliche KO, Josten KM, Kuse R, Hofmann WK, Schrezenmeier H, Novotny J, Anders O,
Eimermacher H, Verbeek W, Kreipe HH, Heimpel H, Aul C, Ganser A:
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as
immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
Leukemia 2004; [Epup ahead of print]

 

Tammen H, Mohring T, Kellmann M, Pich A, Kreipe HH, Hess R:
Mass Spectrometric Phenotyping of Val34Leu Polymorphims of Blood Coagulation Factor XIII by Differential
Peptide Display.
Clin Chem 2004; 50(3): 545-51

 

Tessema M, Lehmann U, Kreipe H:
Cell cycle and no end.
Virchows Achiv 2004; 444: 313-23 [review]

 

Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP:
Long-term outcome of liver transplantation for autoimmune hepatitis.
Clin Transplant 2004;18(1) :62-9

 

Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C,
Tillmann HL:
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient:
immediate switch to adefovir dipivoxil appears to be indicated.
Z Gastroenterol 2004; 42(1): 15-8

 

Wilkens L, Flemming P, Gebel M, Bleck J, Terkamp C, Wingen L, Kreipe H, Schlegelberger B:
Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 2004; 101(5): 1309-14; Epub 2004 Jan 26